OBJECTIVE: To characterize the multidetector CT (MDCT) imaging characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) and collecting duct carcinoma (CDC) of the kidney. METHODS: 21 patients with MTSCC and 18 patients with CDC were studied retrospectively. MDCT was undertaken to investigate differences in tumour characteristics. RESULTS: Five patients with MTSCC had calcifications as did nine patients with CDC (p = 0.108). In three patients with MTSCC and four patients with CDC, the tumours had a clear boundary (p = 0.682). No patient with MTSCC had retroperitoneal lymph node metastasis as did five patients with CDC (p = 0.015). 16 patients with MTSCC showed homogeneous enhancement, whereas 11 patients with CDC showed heterogeneous enhancement (p = 0.025). The attenuation value of CDC tumours was greater than that of MTSCC and normal renal parenchyma on an unenhanced CT (p = 0.027). MTSCC and CDC tumour enhancement was less than the normal renal cortex and medulla in all phases (p < 0.001). Tumour enhancement was greater for CDC than that for MTSCC in all phases (p = 0.011, p = 0.006 and p = 0.052). CONCLUSION: Unenhanced and dynamic MDCT may aid in diagnosis and differentiation of MTSCC and CDC of the kidney. ADVANCES IN KNOWLEDGE: This is the first series evaluating the imaging findings of MTSCC and CDC of which we are aware, and identification of such findings may improve diagnosis of these two rare tumours.
OBJECTIVE: To characterize the multidetector CT (MDCT) imaging characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) and collecting duct carcinoma (CDC) of the kidney. METHODS: 21 patients with MTSCC and 18 patients with CDC were studied retrospectively. MDCT was undertaken to investigate differences in tumour characteristics. RESULTS: Five patients with MTSCC had calcifications as did nine patients with CDC (p = 0.108). In three patients with MTSCC and four patients with CDC, the tumours had a clear boundary (p = 0.682). No patient with MTSCC had retroperitoneal lymph node metastasis as did five patients with CDC (p = 0.015). 16 patients with MTSCC showed homogeneous enhancement, whereas 11 patients with CDC showed heterogeneous enhancement (p = 0.025). The attenuation value of CDC tumours was greater than that of MTSCC and normal renal parenchyma on an unenhanced CT (p = 0.027). MTSCC and CDC tumour enhancement was less than the normal renal cortex and medulla in all phases (p < 0.001). Tumour enhancement was greater for CDC than that for MTSCC in all phases (p = 0.011, p = 0.006 and p = 0.052). CONCLUSION: Unenhanced and dynamic MDCT may aid in diagnosis and differentiation of MTSCC and CDC of the kidney. ADVANCES IN KNOWLEDGE: This is the first series evaluating the imaging findings of MTSCC and CDC of which we are aware, and identification of such findings may improve diagnosis of these two rare tumours.
Authors: James McDaid; Evan A Farkash; David J R Steele; Paulo N Martins; Camille N Kotton; Nahel Elias; Dicken S C Ko; Robert B Colvin; Martin Hertl Journal: Transplantation Date: 2013-03-15 Impact factor: 4.939
Authors: Gladell P Paner; John R Srigley; Anuradha Radhakrishnan; Cynthia Cohen; Brian F Skinnider; Satish K Tickoo; Andrew N Young; Mahul B Amin Journal: Am J Surg Pathol Date: 2006-01 Impact factor: 6.394
Authors: F Cornelis; D Ambrosetti; L Rocher; L E Derchi; B Renard; P Puech; M Claudon; O Rouvière; S Ferlicot; C Roy; M Yacoub; N Grenier; J C Bernhard Journal: Eur Radiol Date: 2016-06-22 Impact factor: 5.315